_id
6919efc73c536f8df2318562
Ticker
UPR.LSE
Name
Uniphar Group PLC
Exchange
LSE
Address
4045 Kingswood Road, Dublin, Ireland, D24 V06K
Country
UK
Sector
Healthcare
Industry
Medical Distribution
Currency
GBX
Website
https://www.uniphar.ie
Description
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source through traditional channels. It is also involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals and veterinary surgeons; operates a network of pharmacies under the Life, Allcare, Hickey's, and McCauley brands. In addition, the company provides pharmacy support, pharmaceutical supply chain and services, medical device distribution, specialist nursing and infusion, outsourcing and resourcing, healthcare technology, medical affairs, online pharmacy and product fostering, and telecommunications support services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
Last Close
2990000
Volume
1890
Current Price
315
Change
0
Last Updated
2025-12-30T11:42:03.265Z
Image
https://logo.clearbit.com/www.uniphar.ie
Ipo Date
-
Market Cap
777433024
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
3.5
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
1485492000
Cost Of Revenue
1265841000
Gross Profit
219651000
Operating Expenses
187045000
Operating Income
32606000
Interest Expense
9033000
Pretax Income
22838000
Net Income
17473000
Eps
0.06615929270555272
Dividends Per Share
3245000
Shares Outstanding
259574298
Income Tax Expense
5345000
EBITDA
45921000
Operating Margin
2.1949630156204143
Total Other Income Expense Net
-9768000
Cash
121076000
Short Term Investments
-
Receivables
348165000
Inventories
218384000
Total Current Assets
687860000
Property Plant Equipment
289839000
Total Assets
1558310000
Payables
662302000
Short Term Debt
26180000
Long Term Debt
311603000
Total Liabilities
1185329000
Equity
372835000
Bs_currency_symbol
EUR
Depreciation
17140000
Change In Working Capital
-116248000
Cash From Operations
17283000
Capital Expenditures
8205000
Cash From Investing
-21632000
Cash From Financing
23106000
Net Change In Cash
121076000
Cf_currency_symbol
-
PE
14.2381
PB
223.13644105301273
ROE
4.686523529175105
ROA
1.1212788212871636
FCF
9078000
Fcf Percent
0.0061111066232601725
Piotroski FScore
3
Health Score
28
Deep Value Investing Score
5.5
Defensive Investing Score
4
Dividend Investing Score
3.5
Economic Moat Investing Score
6.3
Garp Investing Score
3
Growth Investing Score
3.5
Momentum Investing Score
6
Net Net Investing Score
2.5
Quality Investing Score
4
Value Investing Score
4
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
1485492000
Quarters > 0 > income Statement > cost Of Revenue
1265841000
Quarters > 0 > income Statement > gross Profit
219651000
Quarters > 0 > income Statement > operating Expenses
187045000
Quarters > 0 > income Statement > operating Income
32606000
Quarters > 0 > income Statement > interest Expense
9033000
Quarters > 0 > income Statement > pretax Income
22838000
Quarters > 0 > income Statement > net Income
17473000
Quarters > 0 > income Statement > eps
0.06615929270555272
Quarters > 0 > income Statement > dividends Per Share
3245000
Quarters > 0 > income Statement > shares Outstanding
264105000
Quarters > 0 > income Statement > income Tax Expense
5345000
Quarters > 0 > income Statement > EBITDA
45921000
Quarters > 0 > income Statement > operating Margin
2.1949630156204143
Quarters > 0 > income Statement > total Other Income Expense Net
-9768000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
121076000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
348165000
Quarters > 0 > balance Sheet > inventories
218384000
Quarters > 0 > balance Sheet > total Current Assets
687860000
Quarters > 0 > balance Sheet > property Plant Equipment
289839000
Quarters > 0 > balance Sheet > total Assets
1558310000
Quarters > 0 > balance Sheet > payables
662302000
Quarters > 0 > balance Sheet > short Term Debt
26180000
Quarters > 0 > balance Sheet > long Term Debt
311603000
Quarters > 0 > balance Sheet > total Liabilities
1185329000
Quarters > 0 > balance Sheet > equity
372835000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
17473000
Quarters > 0 > cash Flow > depreciation
17140000
Quarters > 0 > cash Flow > change In Working Capital
-116248000
Quarters > 0 > cash Flow > cash From Operations
17283000
Quarters > 0 > cash Flow > capital Expenditures
8205000
Quarters > 0 > cash Flow > cash From Investing
-21632000
Quarters > 0 > cash Flow > cash From Financing
23106000
Quarters > 0 > cash Flow > net Change In Cash
121076000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.06615929270555272
Quarters > 0 > ratios > PB
223.13644105301273
Quarters > 0 > ratios > ROE
4.686523529175105
Quarters > 0 > ratios > ROA
1.1212788212871636
Quarters > 0 > ratios > FCF
9078000
Quarters > 0 > ratios > Piotroski FScore
3
Quarters > 0 > ratios > fcf Percent
0.0061111066232601725
Quarters > 0 > health Score
28
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
1402851000
Quarters > 1 > income Statement > cost Of Revenue
1181944000
Quarters > 1 > income Statement > gross Profit
220907000
Quarters > 1 > income Statement > operating Expenses
171144000
Quarters > 1 > income Statement > operating Income
49763000
Quarters > 1 > income Statement > interest Expense
12613018
Quarters > 1 > income Statement > pretax Income
56385000
Quarters > 1 > income Statement > net Income
48832000
Quarters > 1 > income Statement > eps
0.17886196729117448
Quarters > 1 > income Statement > dividends Per Share
1828000
Quarters > 1 > income Statement > shares Outstanding
273015000
Quarters > 1 > income Statement > income Tax Expense
7535000
Quarters > 1 > income Statement > EBITDA
58773000
Quarters > 1 > income Statement > operating Margin
3.54727622534396
Quarters > 1 > income Statement > total Other Income Expense Net
6622000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
102992000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
237309000
Quarters > 1 > balance Sheet > inventories
201582000
Quarters > 1 > balance Sheet > total Current Assets
553750000
Quarters > 1 > balance Sheet > property Plant Equipment
284796000
Quarters > 1 > balance Sheet > total Assets
1415836000
Quarters > 1 > balance Sheet > payables
375211000
Quarters > 1 > balance Sheet > short Term Debt
31896000
Quarters > 1 > balance Sheet > long Term Debt
241646000
Quarters > 1 > balance Sheet > total Liabilities
1013955000
Quarters > 1 > balance Sheet > equity
401755000
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
48832000
Quarters > 1 > cash Flow > depreciation
17382000
Quarters > 1 > cash Flow > change In Working Capital
27334000
Quarters > 1 > cash Flow > cash From Operations
59741000
Quarters > 1 > cash Flow > capital Expenditures
56341000
Quarters > 1 > cash Flow > cash From Investing
-52426000
Quarters > 1 > cash Flow > cash From Financing
-670000
Quarters > 1 > cash Flow > net Change In Cash
-96004000
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.17886196729117448
Quarters > 1 > ratios > PB
214.06012370723448
Quarters > 1 > ratios > ROE
12.154671379323219
Quarters > 1 > ratios > ROA
3.4489870295712217
Quarters > 1 > ratios > FCF
3400000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.0024236358672446324
Quarters > 1 > health Score
40
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
1367578000
Quarters > 2 > income Statement > cost Of Revenue
1160881000
Quarters > 2 > income Statement > gross Profit
206697000
Quarters > 2 > income Statement > operating Expenses
174471000
Quarters > 2 > income Statement > operating Income
32226000
Quarters > 2 > income Statement > interest Expense
12872982
Quarters > 2 > income Statement > pretax Income
19209000
Quarters > 2 > income Statement > net Income
15328113
Quarters > 2 > income Statement > eps
0.0561438492390528
Quarters > 2 > income Statement > dividends Per Share
3238937
Quarters > 2 > income Statement > shares Outstanding
273015000
Quarters > 2 > income Statement > income Tax Expense
3823000
Quarters > 2 > income Statement > EBITDA
77671000
Quarters > 2 > income Statement > operating Margin
2.3564286643979355
Quarters > 2 > income Statement > total Other Income Expense Net
-13017000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
96004000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
287239000
Quarters > 2 > balance Sheet > inventories
197839000
Quarters > 2 > balance Sheet > total Current Assets
581261000
Quarters > 2 > balance Sheet > property Plant Equipment
251038000
Quarters > 2 > balance Sheet > total Assets
1422287000
Quarters > 2 > balance Sheet > payables
577787000
Quarters > 2 > balance Sheet > short Term Debt
20659000
Quarters > 2 > balance Sheet > long Term Debt
239184000
Quarters > 2 > balance Sheet > total Liabilities
1072100000
Quarters > 2 > balance Sheet > equity
350059000
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
15371000
Quarters > 2 > cash Flow > depreciation
17931828
Quarters > 2 > cash Flow > change In Working Capital
30993283
Quarters > 2 > cash Flow > cash From Operations
64346964
Quarters > 2 > cash Flow > capital Expenditures
23393000
Quarters > 2 > cash Flow > cash From Investing
-43930088
Quarters > 2 > cash Flow > cash From Financing
-10781833
Quarters > 2 > cash Flow > net Change In Cash
96004000
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.0561438492390528
Quarters > 2 > ratios > PB
245.67208670538395
Quarters > 2 > ratios > ROE
4.378722729597011
Quarters > 2 > ratios > ROA
1.077708859041811
Quarters > 2 > ratios > FCF
40953964
Quarters > 2 > ratios > Piotroski FScore
4
Quarters > 2 > ratios > fcf Percent
0.029946346021945368
Quarters > 2 > health Score
31
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
683789000
Quarters > 3 > income Statement > cost Of Revenue
580440500
Quarters > 3 > income Statement > gross Profit
103348500
Quarters > 3 > income Statement > operating Expenses
87235500
Quarters > 3 > income Statement > operating Income
16113000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
9604500
Quarters > 3 > income Statement > net Income
7685500
Quarters > 3 > income Statement > eps
0.028150467923007894
Quarters > 3 > income Statement > dividends Per Share
1624000
Quarters > 3 > income Statement > shares Outstanding
273015000
Quarters > 3 > income Statement > income Tax Expense
1911500
Quarters > 3 > income Statement > EBITDA
21786000
Quarters > 3 > income Statement > operating Margin
2.3564286643979355
Quarters > 3 > income Statement > total Other Income Expense Net
-6508500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
96004000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
287239000
Quarters > 3 > balance Sheet > inventories
197839000
Quarters > 3 > balance Sheet > total Current Assets
581261000
Quarters > 3 > balance Sheet > property Plant Equipment
251038000
Quarters > 3 > balance Sheet > total Assets
1422287000
Quarters > 3 > balance Sheet > payables
577787000
Quarters > 3 > balance Sheet > short Term Debt
20659000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1072100000
Quarters > 3 > balance Sheet > equity
350059000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
7685500
Quarters > 3 > cash Flow > depreciation
8991000
Quarters > 3 > cash Flow > change In Working Capital
-31435500
Quarters > 3 > cash Flow > cash From Operations
32263500
Quarters > 3 > cash Flow > capital Expenditures
11696500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-5409000
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.028150467923007894
Quarters > 3 > ratios > PB
245.67208670538395
Quarters > 3 > ratios > ROE
2.1954870464693093
Quarters > 3 > ratios > ROA
0.5403621069446602
Quarters > 3 > ratios > FCF
20567000
Quarters > 3 > ratios > Piotroski FScore
4
Quarters > 3 > ratios > fcf Percent
0.030077991895160642
Quarters > 3 > health Score
29
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2770429000
Annuals > 0 > income Statement > cost Of Revenue
2342825000
Annuals > 0 > income Statement > gross Profit
427604000
Annuals > 0 > income Statement > operating Expenses
345615000
Annuals > 0 > income Statement > operating Income
81989000
Annuals > 0 > income Statement > interest Expense
25486000
Annuals > 0 > income Statement > pretax Income
75594000
Annuals > 0 > income Statement > net Income
64203000
Annuals > 0 > income Statement > eps
0.23516290313719027
Annuals > 0 > income Statement > dividends Per Share
5076000
Annuals > 0 > income Statement > shares Outstanding
273015000
Annuals > 0 > income Statement > income Tax Expense
11358000
Annuals > 0 > income Statement > EBITDA
136444000
Annuals > 0 > income Statement > operating Margin
2.9594333585159553
Annuals > 0 > income Statement > total Other Income Expense Net
-6395000
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
102992000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
237309000
Annuals > 0 > balance Sheet > inventories
201582000
Annuals > 0 > balance Sheet > total Current Assets
553750000
Annuals > 0 > balance Sheet > property Plant Equipment
284796000
Annuals > 0 > balance Sheet > total Assets
1415836000
Annuals > 0 > balance Sheet > payables
375211000
Annuals > 0 > balance Sheet > short Term Debt
31896000
Annuals > 0 > balance Sheet > long Term Debt
241646000
Annuals > 0 > balance Sheet > total Liabilities
1013955000
Annuals > 0 > balance Sheet > equity
401755000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
85150000
Annuals > 0 > cash Flow > depreciation
35364000
Annuals > 0 > cash Flow > change In Working Capital
48886000
Annuals > 0 > cash Flow > cash From Operations
124268000
Annuals > 0 > cash Flow > capital Expenditures
102088000
Annuals > 0 > cash Flow > cash From Investing
-96479000
Annuals > 0 > cash Flow > cash From Financing
-11488000
Annuals > 0 > cash Flow > net Change In Cash
17340000
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
0.23516290313719027
Annuals > 0 > ratios > PB
206.5850082761882
Annuals > 0 > ratios > ROE
15.980634964095033
Annuals > 0 > ratios > ROA
4.534635367373057
Annuals > 0 > ratios > FCF
22180000
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.008005980301245764
Annuals > 0 > health Score
44
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2553062000
Annuals > 1 > income Statement > cost Of Revenue
2163078000
Annuals > 1 > income Statement > gross Profit
389984000
Annuals > 1 > income Statement > operating Expenses
322276000
Annuals > 1 > income Statement > operating Income
67708000
Annuals > 1 > income Statement > interest Expense
24593000
Annuals > 1 > income Statement > pretax Income
52898000
Annuals > 1 > income Statement > net Income
44815000
Annuals > 1 > income Statement > eps
0.16414849000970644
Annuals > 1 > income Statement > dividends Per Share
4832000
Annuals > 1 > income Statement > shares Outstanding
273015000
Annuals > 1 > income Statement > income Tax Expense
7750000
Annuals > 1 > income Statement > EBITDA
112897000
Annuals > 1 > income Statement > operating Margin
2.6520311688474467
Annuals > 1 > income Statement > total Other Income Expense Net
-14810000
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
85652000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
202849000
Annuals > 1 > balance Sheet > inventories
184549000
Annuals > 1 > balance Sheet > total Current Assets
507934000
Annuals > 1 > balance Sheet > property Plant Equipment
206700000
Annuals > 1 > balance Sheet > total Assets
1289561000
Annuals > 1 > balance Sheet > payables
299184000
Annuals > 1 > balance Sheet > short Term Debt
33302000
Annuals > 1 > balance Sheet > long Term Debt
222604000
Annuals > 1 > balance Sheet > total Liabilities
955941000
Annuals > 1 > balance Sheet > equity
332802000
Annuals > 1 > balance Sheet > currency_symbol
GBX
Annuals > 1 > cash Flow > net Income
77755000
Annuals > 1 > cash Flow > depreciation
35406000
Annuals > 1 > cash Flow > change In Working Capital
-16224000
Annuals > 1 > cash Flow > cash From Operations
52511000
Annuals > 1 > cash Flow > capital Expenditures
31954000
Annuals > 1 > cash Flow > cash From Investing
-90428000
Annuals > 1 > cash Flow > cash From Financing
19630000
Annuals > 1 > cash Flow > net Change In Cash
-18052000
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
0.16414849000970644
Annuals > 1 > ratios > PB
249.38720320190384
Annuals > 1 > ratios > ROE
13.465964747808007
Annuals > 1 > ratios > ROA
3.475213657981282
Annuals > 1 > ratios > FCF
20557000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.008051900032196633
Annuals > 1 > health Score
42
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2070669000
Annuals > 2 > income Statement > cost Of Revenue
1763925000
Annuals > 2 > income Statement > gross Profit
306744000
Annuals > 2 > income Statement > operating Expenses
253589000
Annuals > 2 > income Statement > operating Income
53155000
Annuals > 2 > income Statement > interest Expense
8833500
Annuals > 2 > income Statement > pretax Income
54676000
Annuals > 2 > income Statement > net Income
45587000
Annuals > 2 > income Statement > eps
0.1737071133533509
Annuals > 2 > income Statement > dividends Per Share
4666000
Annuals > 2 > income Statement > shares Outstanding
262436000
Annuals > 2 > income Statement > income Tax Expense
8970000
Annuals > 2 > income Statement > EBITDA
92436000
Annuals > 2 > income Statement > operating Margin
2.5670447570326305
Annuals > 2 > income Statement > total Other Income Expense Net
1521000
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
103704000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
142300000
Annuals > 2 > balance Sheet > inventories
157656000
Annuals > 2 > balance Sheet > total Current Assets
427172000
Annuals > 2 > balance Sheet > property Plant Equipment
166628000
Annuals > 2 > balance Sheet > total Assets
1110794000
Annuals > 2 > balance Sheet > payables
223249000
Annuals > 2 > balance Sheet > short Term Debt
21805000
Annuals > 2 > balance Sheet > long Term Debt
187431000
Annuals > 2 > balance Sheet > total Liabilities
821011000
Annuals > 2 > balance Sheet > equity
289544000
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
69570000
Annuals > 2 > cash Flow > depreciation
28470000
Annuals > 2 > cash Flow > change In Working Capital
-9496000
Annuals > 2 > cash Flow > cash From Operations
82831000
Annuals > 2 > cash Flow > capital Expenditures
19921000
Annuals > 2 > cash Flow > cash From Investing
-106332000
Annuals > 2 > cash Flow > cash From Financing
50405000
Annuals > 2 > cash Flow > net Change In Cash
25679000
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
0.1737071133533509
Annuals > 2 > ratios > PB
275.53858480921724
Annuals > 2 > ratios > ROE
15.744411902854145
Annuals > 2 > ratios > ROA
4.104001281965873
Annuals > 2 > ratios > FCF
62910000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.030381485403992624
Annuals > 2 > health Score
46
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
1943149000
Annuals > 3 > income Statement > cost Of Revenue
1668652000
Annuals > 3 > income Statement > gross Profit
274497000
Annuals > 3 > income Statement > operating Expenses
229350000
Annuals > 3 > income Statement > operating Income
45147000
Annuals > 3 > income Statement > interest Expense
6926000
Annuals > 3 > income Statement > pretax Income
55801000
Annuals > 3 > income Statement > net Income
48077000
Annuals > 3 > income Statement > eps
0.17822666745751653
Annuals > 3 > income Statement > dividends Per Share
5731000
Annuals > 3 > income Statement > shares Outstanding
269752000
Annuals > 3 > income Statement > income Tax Expense
7679000
Annuals > 3 > income Statement > EBITDA
89657000
Annuals > 3 > income Statement > operating Margin
2.3233936255016987
Annuals > 3 > income Statement > total Other Income Expense Net
10654000
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
78025000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
129468000
Annuals > 3 > balance Sheet > inventories
112312000
Annuals > 3 > balance Sheet > total Current Assets
343994000
Annuals > 3 > balance Sheet > property Plant Equipment
152483000
Annuals > 3 > balance Sheet > total Assets
944993000
Annuals > 3 > balance Sheet > payables
186892000
Annuals > 3 > balance Sheet > short Term Debt
16079000
Annuals > 3 > balance Sheet > long Term Debt
124601000
Annuals > 3 > balance Sheet > total Liabilities
693429000
Annuals > 3 > balance Sheet > equity
251444000
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
59551000
Annuals > 3 > cash Flow > depreciation
26930000
Annuals > 3 > cash Flow > change In Working Capital
-9055000
Annuals > 3 > cash Flow > cash From Operations
52177000
Annuals > 3 > cash Flow > capital Expenditures
14429000
Annuals > 3 > cash Flow > cash From Investing
-49658000
Annuals > 3 > cash Flow > cash From Financing
13259000
Annuals > 3 > cash Flow > net Change In Cash
17615000
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
0.17822666745751653
Annuals > 3 > ratios > PB
326.1346780992984
Annuals > 3 > ratios > ROE
19.12036079604206
Annuals > 3 > ratios > ROA
5.087550913075547
Annuals > 3 > ratios > FCF
37748000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.01942619943195298
Annuals > 3 > health Score
49
Valuation > metrics > PE
14.2381
Valuation > metrics > PB
223.13644105301273
Valuation > final Score
50
Valuation > verdict
3668.9% Overvalued
Profitability > metrics > ROE
4.686523529175105
Profitability > metrics > ROA
2.540197133137557
Profitability > metrics > Net Margin
0.011762432917848094
Profitability > final Score
19
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.1792320999906125
Risk > metrics > Interest Coverage
3.60965349274881
Risk > final Score
20
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.9990965631635976
Liquidity > metrics > Quick Ratio
0.6819001803968732
Liquidity > final Score
44
Liquidity > verdict
Weak
Prev Valuations > 0
40
Prev Valuations > 1
40
Prev Valuations > 2
40
Prev Profitabilities > 0
56
Prev Profitabilities > 1
18
Prev Profitabilities > 2
10
Prev Risks > 0
34
Prev Risks > 1
16
Prev Risks > 2
11
Prev Liquidities > 0
77
Prev Liquidities > 1
42
Prev Liquidities > 2
42
Updated At
2026-01-20T23:04:43.540Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-23
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
0.1124
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-09-01
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.0853
Earnings History > 1 > eps Estimate
0.0747
Earnings History > 1 > eps Difference
0.0106
Earnings History > 1 > surprise Percent
14.1901
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-04-01
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.18
Earnings History > 2 > eps Estimate
0.1074
Earnings History > 2 > eps Difference
0.0726
Earnings History > 2 > surprise Percent
67.5978
Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source through traditional channels. It is also involved in the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals and veterinary surgeons; operates a network of pharmacies under the Life, Allcare, Hickey's, and McCauley brands. In addition, the company provides pharmacy support, pharmaceutical supply chain and services, medical device distribution, specialist nursing and infusion, outsourcing and resourcing, healthcare technology, medical affairs, online pharmacy and product fostering, and telecommunications support services, as well as specialist provider of pharmaceuticals. Uniphar plc was founded in 1967 and is headquartered in Dublin, Ireland.
Stock Price
GBp 0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHow can political science explain the rise of the National Front (FN) in France? The London School of Economics and Political Science
Read more →Showing 2 of 4
(Last Updated 2025-06-30)
Rating:
BUY
$
Analyst Picks
Strong Buy
0
Buy
1
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Uniphar Group PLC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.1124
Date
2025-06-30
EPS Actual
0.0853
EPS Estimate
0.0747
EPS Difference
0.0106
Surprise Percent
14.1901%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
ÂŁ 0
Cost Of Revenue
ÂŁ 0
Gross Profit
ÂŁ 0
Operating Expenses
ÂŁ 0
Operating Income
ÂŁ 0
Interest Expense
ÂŁ 0
Pretax Income
ÂŁ 0
Net Income
ÂŁ 0
Income Tax Expense
ÂŁ 0
EBITDA
ÂŁ 0
Total Other Income Expense Net
ÂŁ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
ÂŁ 0
Short Term Investments
ÂŁ 0
Receivables
ÂŁ 0
Inventories
ÂŁ 0
Total Current Assets
ÂŁ 0
Property Plant Equipment
ÂŁ 0
Total Assets
ÂŁ 0
Payables
ÂŁ 0
Short Term Debt
ÂŁ 0
Long Term Debt
ÂŁ 0
Total Liabilities
ÂŁ 0
Equity
ÂŁ 0
(Last Updated 2025-06-30)
Net Income
ÂŁ 0
Depreciation
ÂŁ 0
Change In Working Capital
ÂŁ 0
Cash From Operations
ÂŁ 0
Capital Expenditures
ÂŁ 0
Cash From Investing
ÂŁ 0
Cash From Financing
ÂŁ 0
Net Change In Cash
ÂŁ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.